Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Taisho Pharmaceutical Co Ltd
Taisho Pharmaceutical Co Ltd_20100107
Taisho Pharmaceutical Co Ltd_20131212
Taisho Pharmaceutical Co Ltd_20100128

Taisho Pharmaceutical Co Ltd patents

Recent patent applications related to Taisho Pharmaceutical Co Ltd. Taisho Pharmaceutical Co Ltd is listed as an Agent/Assignee. Note: Taisho Pharmaceutical Co Ltd may have other listings under different names/spellings. We're not affiliated with Taisho Pharmaceutical Co Ltd, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Taisho Pharmaceutical Co Ltd-related inventors

Date Taisho Pharmaceutical Co Ltd patents (updated weekly) - BOOKMARK this page
09/21/17C-4" position substituted macrolide derivative
07/27/17Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
10/06/162-pyridone compound
06/09/16Glycine transporter inhibitor
05/12/16Glycine transporter inhibitor
04/07/16Phenylpyrrole derivative
12/31/15Prophylactic or therapeutic drug for constipation
12/03/15Orally administered liquid formulation
12/03/15Orally administered liquid formulation
11/19/15Aqueous carbonated beverage
11/12/15Combinations of sglt 2 inhibitors and antihypertensive drugs
08/13/15Novel hydroxamic acid derivative
07/16/15Composition for agent for external use
07/02/15Heteroaromatic methyl cyclic amine derivative
06/25/15Partially saturated nitrogen-containing heterocyclic compound
06/18/15Branched chain alkyl heteroaromatic ring derivative
05/21/15Prodrug of fluorine-containing amino acid
02/12/15Fused azole derivative
02/12/15Phenyltriazole derivative
11/06/14Phenylpyrrole derivative
09/18/14Azole derivative
08/14/14Methylpiperidine derivative
06/05/14Amidine compound or salt thereof
04/03/14Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof
03/20/14Heteroaromatic ring derivative
02/13/14C-4" position substituted macrolide derivative
01/02/14Nitrogen-containing condensed heterocyclic compound
12/26/13Azole derivative
12/12/13Glycine transporter-inhibiting substances
10/24/13Pyrazole derivative
08/01/131, 2, 4-triazolone derivative
07/18/13Glycine transporter inhibiting substances
06/27/134-isopropyl-6-methoxyphenyl glucitol compound
06/06/13Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof
05/30/13Heteroaryl-pyrazole derivative
05/16/13Ethinyl-pyrazole derivative
04/18/13Isoquinoline derivative
03/21/13Novel hydroxamic acid derivative
01/10/13Pigment composition
01/03/13Pigment composition
12/20/12Tablet manufacturing method
12/13/12Extended release preparation
09/20/12Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof
09/13/12Process for producing optically active bicyclo [3.1.0] hexane derivative using enzyme
08/30/12Aminothiazole derivative
07/26/12Composition for lowering blood uric acid level
07/05/12Compounds having tafia inhibitory activity
02/16/12Pharmaceutical compositions
02/02/122-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
01/26/12Dihydroquinolinone derivatives
01/26/12External preparation comprising prostaglandin derivative
01/12/12Glycine transporter inhibiting substances
01/05/122-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
12/15/114-isopropylphenyl glucitol compounds as sglt1 inhibitors
11/24/11Isoquinoline derivative
11/03/11Triazole derivative
09/01/11Compound having tafia inhibitory activity
07/21/117-piperidinoalkyl-3, 4-dihydroquinolone derivative
06/09/11Pyrrolopyrimidine and pyrrolotriazine derivatives
06/02/11Pyrrolopyridine derivatives substituted with cyclic amino group
05/26/11Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
04/28/111-thio-d-glucitol derivatives
04/07/11Coating apparatus
03/17/11Phenylpyrazole derivatives
03/17/11Phenylpyrazole derivatives
Patent Packs
03/17/11Method of producing bicyclo[3.1.0] hexane derivative using enzyme
11/25/10Pyrazolopyrimidine compound
11/25/102-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
10/21/10Phenylpyrazole derivatives
09/30/10Novel naphthyridine derivative monohydrate and producing the same
09/16/10Inhibitor of binding of s1p1
08/26/10Thiazole derivative
08/12/10Prostaglandin deriative-containing aqueous liquid preparation
07/15/10Compound having 11beta-hsd1 inhibitory activity
07/01/10Novel nitrogenated heterocyclic compound and salt thereof
06/17/10Emulsion lotion
04/01/101-naphthyl alkylpiperidine derivative
03/18/101-phenyl 1-thio-d-glucitol derivative
01/28/10C-phenyl glycitol compound
01/28/10Prophylactic or therapeutic agent for alopecia
Patent Packs
01/07/10C-phenyl 1-thioglucitol compound
12/10/092-amino-bicyclo (3.1.0) hexane-2,6-dicarboxylic ester derivative
08/06/09Novel heterocyclic compound or salt thereof and intermediate thereof
07/16/09Binding inhibitor of sphingosine-1-phosphate
06/18/09Drug for inhibiting vascular intimal hyperplasia
05/21/09Triazole derivative
04/30/09Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
04/02/09Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli
03/19/09Macrolide derivatives
12/12/13Glycine transporter-inhibiting substances
01/28/10Prophylactic or therapeutic agent for alopecia
01/07/10C-phenyl 1-thioglucitol compound

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Taisho Pharmaceutical Co Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Taisho Pharmaceutical Co Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by